J. Hui

发表

T. Arakawa, T. Horan, A. Welcher, 1998, The Journal of Biological Chemistry.

Selective reduction of the intermolecular disulfide bridge in human glial cell line-derived neurotrophic factor using tris-(2-carboxyethyl) phosphine

V. Katta, M. Haniu, M. Rohde, 1997 .

Determination of disulfide structure in agouti-related protein (AGRP) by stepwise reduction and alkylation.

V. Katta, D. Chow, E. Bures, 1998, Biochemistry.

Peptidomimetic Inhibitors of Human Immunodeficiency Virus Protease ( HIV‐PR): Design, Enzyme Binding and Selectivity, Antiviral Efficacy, and Cell Permeability Properties.

D. Decamp, C. Craik, W. Lowther, 1995 .

The Intermolecular Disulfide Bridge of Human Glial Cell Line-Derived Neurotrophic Factor: Its Selective Reduction and Biological Activity of the Modified Protein

T. Osslund, D. Chow, M. Haniu, 1999, Journal of protein chemistry.

A structural model to explain the partial catalytic activity of human prorenin.

R. Heinrikson, R. Poorman, J. Hui, 1989, American journal of hypertension.

Inhibitors of the protease from human immunodeficiency virus: synthesis, enzyme inhibition, and antiviral activity of a series of compounds containing the dihydroxyethylene transition-state isostere.

W. Howe, A. Tomasselli, R. Heinrikson, 1993, Journal of medicinal chemistry.

Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.

A. Tomasselli, R. Heinrikson, T. Sawyer, 1990, Biochemistry.

Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitors.

R. Borchardt, J. Fisher, K. Ng, 1994, Journal of medicinal chemistry.

Glial cell line-derived neurotrophic factor: selective reduction of the intermolecular disulfide linkage and characterization of its disulfide structure.

V. Katta, M. Haniu, M. Rohde, 1996, Biochemistry.

Purification and characterization of heterodimeric human immunodeficiency virus type 1 (HIV-1) reverse transcriptase produced by in vitro processing of p66 with recombinant HIV-1 protease.

A. Tomasselli, R. Heinrikson, D. B. Evans, 1992, The Journal of biological chemistry.

The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors.

A. Tomasselli, R. Heinrikson, K. Watenpaugh, 1993, The Journal of biological chemistry.

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.

D. Decamp, C. Craik, W. Howe, 1990, The Journal of biological chemistry.

Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus.

A. Tomasselli, R. Heinrikson, B. Greenberg, 1991, The Journal of biological chemistry.

PADLOC: a powerful tool to assign disulfide bond connectivities in peptides and proteins by NMR spectroscopy.

L. Poppe, P. Schnier, Justin K. Murray, 2012, Analytical chemistry.

Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties.

V. Katta, M. Citron, R. Vassar, 2000 .

Characterization of Alzheimer's β-Secretase Protein BACE

V. Katta, M. Citron, R. Vassar, 2000, The Journal of Biological Chemistry.

Zinc inhibition of renin and the protease from human immunodeficiency virus type 1.

A. Tomasselli, I. Reardon, R. Heinrikson, 1991, Biochemistry.

Development and evaluation of on-line nanoliter flow analysis of protein digests by pneumatic-splitter electrospray liquid chromatography mass spectrometry

V. Katta, M. Haniu, M. Rohde, 1997 .

The evaluation of non-viral substrates of the HIV protease as leads in the design of inhibitors for AIDS therapy.

T K Sawyer, A. Tomasselli, R. Heinrikson, 1991, Advances in experimental medicine and biology.

Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity.

W. Howe, A. Tomasselli, R. Heinrikson, 1991, Journal of medicinal chemistry.

Crystal structure of a complex of HIV‐1 protease with a dihydroxyethylene‐containing inhibitor: Comparisons with molecular modeling

Narmada Thanki, Alexander Wlodawer, A. Wlodawer, 1992, Protein science : a publication of the Protein Society.

Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease.

I. Pastan, A. Tomasselli, R. Heinrikson, 1990, The Journal of biological chemistry.

E. coli-expressed human neurotrophin-3 characterization of a C-terminal extended product

M. Haniu, L. Tsai, M. Rohde, 1995 .

Could angiotensin I be produced from a renin substrate by the HIV-1 protease?

R. Heinrikson, D. B. Evans, J. Hui, 1991, Analytical biochemistry.

Dimerization and activation of porcine pancreatic phospholipase A2 via substrate level acylation of lysine 56.

A. Tomasselli, I. Reardon, R. Heinrikson, 1989, The Journal of biological chemistry.

Human neurotrophin-3: A one-step peptide mapping method and complete disulfide characterization of the recombinant protein

V. Katta, M. Rohde, R. Rosenfeld, 1996, Journal of protein chemistry.

Native and Denaturing MS Protein Deconvolution for Biopharma: Monoclonal Antibodies and Antibody-Drug-Conjugates to Polydisperse Membrane Proteins and Beyond.

I. Campuzano, J. Loo, M. Bern, 2019, Analytical chemistry.

Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates

I. Pastan, A. Tomasselli, I. Reardon, 1990, Journal of virology.

Calcium‐free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2

D. Decamp, C. Craik, W. Howe, 1991, Proteins.

Large scale purification and refolding of HIV-1 protease fromEscherichia coli inclusion bodies

D. P. Brunner, J. Hui, J. Lull, 1993, Journal of protein chemistry.

Human Dickkopf‐1 (huDKK1) protein: Characterization of glycosylation and determination of disulfide linkages in the two cysteine‐rich domains

T. Horan, C. Spahr, M. Haniu, 2011, Protein science : a publication of the Protein Society.

Peptidomimetic inhibitors of human immunodeficiency virus protease (HIV-PR): Design, enzyme binding and selectivity, antiviral efficacy, and cell permeability properties

D. Decamp, C. Craik, W. Lowther, 1993 .

Biochemical, biophysical, and pharmacological characterization of bacterially expressed human agouti-related protein.

V. Katta, J. Philo, J. Delaney, 1998, Biochemistry.

Ribonuclease A as a substrate of the protease from human immunodeficiency virus-1.

A. Tomasselli, R. Heinrikson, J. Hui, 1990, The Journal of biological chemistry.

HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogs.

T K Sawyer, W. Howe, A. Tomasselli, 2009, International journal of peptide and protein research.

Identification of Asp95as the Site of Succinimide Formation in Recombinant Human Glial Cell Line-Derived Neurotrophic Factor

Michael F. Rohde, John H. Robinson, V. Katta, 1998 .

Differentiation of Aspartic and Isoaspartic Acid Using 193 nm Ultraviolet Photodissociation Mass Spectrometry.

Iain D G Campuzano, J. Brodbelt, Qingchun Zhang, 2023, Analytical chemistry.